Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2005-09-27
2005-09-27
Horlick, Kenneth R. (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007100
Reexamination Certificate
active
06949342
ABSTRACT:
Methods identifying prostate cancer, methods for prognosing and diagnosing prostate cancer, methods for identifying a compound that modulates prostate cancer development, methods for determining the efficacy of a prostate cancer therapy, and oligonucleotide microarrays containing probes for genes involved in prostate cancer development are described.
REFERENCES:
patent: 6476207 (2002-11-01), Zhang et al.
patent: 2002/0068036 (2002-06-01), Hevezi et al.
patent: 2003/0013097 (2003-01-01), Welsh et al.
patent: 2003/0113762 (2003-06-01), Warrington
Constantine, L. and Harrington, C., “Use of GeneChip High-Density Oligonucleotide Arrays for Gene Expression Monitoring,”Life Science News, pp. 11-14 (1998).
Schena, M., et al., “Parallel Human Genome Analysis: Microarray-Based Expression Monitoring of 1000 Genes,”Proceedings of the National Academy of Sciences U.S.A., 93:10614-10619 (1996).
Xu, J., et al., “Identification of Differentially Expressed Genes In Human Prostate Cancer Using Subtraction and Microarray,”Cancer Research, 60:1677-1682 (2000).
Dhanasekaran, S.M., et al., “Delineation of Prognostic Biomarkers in Prostate Cancer,”Nature, 412:822-826 (2001).
Eklöv, S., et al., “Lack of the Latent Transforming Growth Factor β Binding Protein in Malignant, But Not Benign Prostatic Tissue,”Cancer Research, 53:3193-3197 (1993).
Jensen, S.L., et al., “Increased Levels of nm23 H1/Nucleoside Diphosphate Kinase A mRNA Associated with Adenocarcinoma of the Prostate,”World Journal of Urology, 14: S21-S25 (1996).
Myers, R.B., et al., “Expression of nm23-H1 in Prostatic Intraepithelial Neoplasia and Adenocarcinoma,”Human Pathology, 27:1021-1024 (1996).
Nelson, W.G., et al., “The Molecular Pathogenesis of Prostate Cancer: Implications for Prostate Cancer Prevention,”Urology, 57 (Supp. 4A): 39-45 (2001).
Poczateck, R.B., et al., “Ep-CAM Levels in Prostatic Adenocarcinoma and Prostatic Intraepithelial Neoplasia,”The Journal of Urology, 162: 1462-1466 (1999).
Saverio, B., et al., “Tumor Progression is Accompanied by Significant Changes in the Levels of Expression of Polyamine Metabolism Regulatory Genes and Clusterin (Sulfated Glycoprotein 2) in Human Prostate Cancer Specimens,”Cancer Research, 60:28-34 (2000).
Sellers, W.R., “Analysis of Gene Expression in Prostate Cancer,” Institutes of Health Directors' Challenge Group Presentation, Apr., 2001.
Silver, D.A., et al., “Prostate-specific Membrane Antigen Expression in Normal and Malignant Human Tissues,”Clinical Cancer Research, 3:81-85 (1997).
Welsh, J.B., et al., “Analysis of Gene Expression Identifies Candidate Markers and Pharmacological Targets in Prostate Cancer,”Cancer Research, 61:5974-5978 (2001).
Yang, M., et al., “Differential Expression and Androgen Regulation of the Human Selenium-Binding Protein Gene hSP56 in Prostate Cancer Cells,”Cancer Research, 58:3150-3153 (1998).
Chetcuti, A., et al., “Loss of Annexin II Heavy and Light Chains in Prostate Cancer and Its Precursors,”Cancer Research, 61:6331-6334 (2001).
Cornford, P.A., et al., “Heat Shock Protein Expression Independently Predicts Clinical Outcome in Prostate Cancer,”Cancer Research, 60:7099-7105 (2000).
Djonov, V., et al., “Transforming Growth Factor-β3 is Expressed in Nondividing Basal Epithelial Cells in Normal Human Prostate and Benign Prostatic Hyperplasia, and Is No Longer Detectable in Prostate Carcinoma,”The Prostate, 31:103-109 (1997).
Febbo Phillip G.
Golub Todd R.
Ross Kenneth N.
Sellers William R.
Dana-Farber Cancer Institute Inc.
Fish & Neave IP Group
Horlick Kenneth R.
Whitehead Institute for Biomedical Research
LandOfFree
Prostate cancer diagnosis and outcome prediction by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostate cancer diagnosis and outcome prediction by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostate cancer diagnosis and outcome prediction by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3402175